Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab in Synovial Sarcoma
NCT00104949Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Jul 2005
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of trastuzumab in synovial sarcoma (SS), sponsored by SWOG Cancer Research Network. Started Jul 2005; status: completed.
02
Drugs
03
Conditions
synovial sarcoma (SS)
Beyond the preview
Go deeper on NCT00104949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104949.